BMS-207147, ER-30346
- BMS 207147
- ER 30346
- Ravuconazole
- UNII-95YH599JWV
CAS Registry Number: 182760-06-1
CAS Name: 4-[2-[(1R,2R)-2-(2,4-Difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-4-thiazolyl]benzonitrile
Additional Names: (2R,3R)-3-[4-(4-cyanophenyl)thiazol-2-yl]-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol
(2R,3R)-3-i4-(4-cvanophenyl)thiazol-2-yl1-1 -(1 H-1 ,2,4-triazol-1 -yl)-2-(2,4-difluorophenyl)- butan-2-ol
 [R-(R*,R*)]-4-[2-[2-(2,4-Difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-4-thiazolyl]benzonitrile
4-[2-[(1R,2R)-2-(2,4-Difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-4-thiazolyl]benzonitrile
4-[2-[(1R,2R)-2-(2,4-Difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-4-thiazolyl]benzonitrile
Molecular Formula: C22H17F2N5OS
Molecular Weight: 437.47
Percent Composition: C 60.40%, H 3.92%, F 8.69%, N 16.01%, O 3.66%, S 7.33%
Eisai (INNOVATOR)
Properties: Colorless prisms from diisopropyl ether/n-hexane, mp 164-166°. [a]D24=  -29.1° (c = 1.03 in methanol).
Melting point: mp 164-166°
Optical Rotation: [a]D24=  -29.1° (c = 1.03 in methanol)
Therap-Cat: Antifungal.
m.p. 164-166° C; [a]=-30° (c=1 , methanol, 25° C); 
NMR (CDCI3): 1 .23(3H, d, J=8 Hz), 4.09(1 H, q, J=8Hz), 4.26(1 H, d, J=14Hz), 4.92(1 H, d, J=14Hz), 5.75(1 H, s), 6.75- 6.85(2H, m), 7.45-7.54(2H, m), 7.62(1 H, s), 7.69(1 H, s), 7.75(1 H, d, J=8Hz), 7.86(1 H, s), 8.03(1 H,d,J=8Hz). 
The analytical data were identical with published (US5648372 and Chem. Pharm. Bull. 1998, 46, 623-630).
1H NMR PREDICT
13 C NMR PREDICT

- Improved Chiral Synthesis of Ravuconazole - Taylor ...www.tandfonline.com/doi/pdf/10.1080/00397910802563420by L Xu - 2009 - Cited by 6 - Related articlesdeveloped also a new convergent synthesis of ravuconazole.[7] The key step of this ... electivity (determined by NMR to be 16:1) seemed better. As expected, the- ... 
[a]D 20¼ 30.2 (c ¼ 1, MeOH).
IR (KBr): 2226, 1608, 1500, 1138 cm1 .
1 H NMR (DMSO-d6) d: 8.41 (s, 1 H), 8.20 (s, 1 H), 8.18 (d, J ¼ 8.4 Hz, 2 H), 7.91 (d, J ¼ 8.4 Hz, 2 H), 7.61 (s, 1 H), 7.26–7.30 (m, 1 H), 7.18– 7.23 (m, 1 H), 6.91–6.95 (m, 1 H), 6.07 (s, 1 H), 4.85 (d, J ¼ 14.4 Hz, 1 H), 4.35 (d, J ¼ 14.4 Hz, 1 H), 4.07 (q, J ¼ 7.2 Hz, 1 H), 1.12 (d, J ¼ 7.2 Hz, 3 H).
13C NMR (DMSO-d6) d: 172.45, 162.57 (dd, 1 JCF ¼ 245 Hz, 3 JCF ¼ 12.1 Hz), 159.33 (dd, 1 JCF ¼ 245 Hz, 3 JCF ¼ 12.1 Hz), 152.02, 151.12, 138.99, 145.41, 133.58, 130.90, 127.39, 125.30 (d, 2 JCF ¼ 14 Hz), 119.61, 119.09, 111.57 (d, 2 JCF ¼ 19.7 Hz), 110.78, 104.70 (d, 3 JCF ¼ 6 Hz), 76.89 (d, 2 JCF ¼ 26.6 Hz), 56.64, 45.21,17.25.
MS (API-ES) m=z 438.0.
Anal. calcd. for C22H17F2 N5OS: C, 60.40; H, 3.92; F, 8.69; N, 16.01; S, 7.33. Found: C, 60.56; H, 3.93; F, 8.76; N, 15.76; S, 7.36. AC
Lin Xu , Marc R. Muller , Xiong Yu & Bao-Quan Zhu (2009) Improved Chiral Synthesis of Ravuconazole, Synthetic Communications: An International Journal for Rapid Communication of Synthetic Organic Chemistry, 39:9, 1611-1625, DOI: 10.1080/00397910802563420
 COCK SAYS MOM CAN TEACH YOU NMR
COCK SAYS MOM CAN TEACH YOU NMR
 
 DRUG APPROVALS BY DR ANTHONY MELVIN CRASTO .....FOR BLOG HOME CLICK HERE
DRUG APPROVALS BY DR ANTHONY MELVIN CRASTO .....FOR BLOG HOME CLICK HERE

